According to a new report by Polaris Market Research, the global vaccine contract manufacturing market was valued at USD 4.61 billion in 2023 and is projected to reach USD 13.16 billion by 2032, expanding at a CAGR of 12.4% over the forecast period. Growth is underpinned by rising global demand for preventive healthcare, expanding biopharmaceutical manufacturing complexity, and accelerating reliance on contract manufacturing organizations (CMOs) across human and veterinary vaccine development.

What Is Driving Vaccine Contract Manufacturing Market Growth?

Demand is climbing as growing awareness of vaccination benefits converges with the ongoing development of vaccines for emerging infectious, oncological, and autoimmune conditions. Pharmaceutical companies and governments are increasingly prioritizing capacity, flexibility, and regulatory expertise, pushing contract manufacturing adoption across global vaccine supply chains. Polaris analysts note that the diversification of vaccine supply chains across regions positions CMOs for sustained double-digit growth through 2032, with downstream processing emerging as the largest revenue contributor and inactivated vaccine production posting some of the fastest incremental gains.

Key Trends Shaping the Vaccine Contract Manufacturing Industry

Advanced Biopharmaceutical Manufacturing Techniques

Advancements in cell culture and recombinant DNA technology are making vaccine production more complex, favoring contract manufacturers with specialized biologics expertise and driving broader technology advancement across the industry.

Regulatory and Quality Compliance Pressure

Changes to manufacturing processes, facilities, or raw materials increasingly trigger new clinical and regulatory requirements, reinforcing the value of CMOs with proven regulatory landscape navigation and quality assurance capabilities.

Regional Supply Chain Diversification

Governments and manufacturers are pursuing regional vaccine production capacity to strengthen supply security and enable faster response to localized outbreaks, a shift that is reshaping the market outlook and competitive landscape for CMOs worldwide.

Explore The Complete Comprehensive Report Here:

https://www.polarismarketresearch.com/industry-analysis/vaccine-contract-manufacturing-market 

Market Segmentation: Breaking Down the Vaccine Contract Manufacturing Market

Polaris segments the vaccine contract manufacturing market by vaccine type, application, process, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Vaccine Type

The inactivated vaccine segment is expected to register the fastest CAGR through 2032, supported by continued regulatory approvals for inactivated candidates across various medical conditions. DNA vaccines are also advancing through clinical research and show strong long-term potential, while the subunit vaccine segment is projected to grow steadily as recombinant research targeting conditions such as Hepatitis C continues.

By Application

The veterinary segment held a significant share of revenue in 2022, supported by the growing role of vaccination in reducing antibiotic use in livestock and meeting rising global demand for animal-derived food, signaling where near-term demand around veterinary vaccine manufacturing is shifting.

By Process

The downstream segment held the largest market share in 2022, reflecting the substantial investment, skilled workforce, and advanced biotechnological tools required for product recovery and purification, the final and most resource-intensive stage of vaccine manufacturing.

By Region

North America captured the largest share of the market in 2022, supported by advanced biopharmaceutical infrastructure and a dense concentration of specialized CMOs. Asia Pacific is expected to register the fastest CAGR through 2032 as cost-effective manufacturing and a skilled biotechnology workforce attract growing outsourcing activity.

Regional Outlook: Where Is the Vaccine Contract Manufacturing Market Growing Fastest?

North America led the market in 2022, leveraging advanced biopharmaceutical infrastructure and a broad base of specialized CMOs that demonstrated rapid agility during the COVID-19 pandemic, while Asia Pacific is expected to post the fastest CAGR through 2032, driven by cost-effective manufacturing and a growing skilled biotechnology workforce. Within North America, the United States remains the largest single market; within Asia Pacific, countries such as South Korea and China are emerging as primary growth engines. Europe rounds out the top regions, supported by established pharmaceutical manufacturing capacity.

Competitive Landscape: Leading Vaccine Contract Manufacturing Market Companies

Key players profiled in the report include AGC Biologics, Catalent, Inc., Charles River Laboratories, Emergent BioSolutions, Lonza Group, and WuXi Biologics, who are focusing on capacity expansion, technology upgrades, and strategic partnerships to strengthen market position across the downstream processing and inactivated vaccine segments outlined above. A recent move includes Moderna's August 2022 partnership with the Canadian government to establish a domestic mRNA vaccine manufacturing facility, aimed at deepening regional production capacity for respiratory virus vaccines.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the vaccine contract manufacturing market forecast, this report benchmarks market share, segment-level pricing, and forecast data — by vaccine type, application, process, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing CMO suppliers, investors sizing entry points, and strategy teams tracking veterinary vaccine manufacturing as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Magnetic Sensor Market

Drone Software Market

Anticoagulant Rodenticides Market

Muscle Stimulator Market

Pin Mills Market

Pin Mills Market

Lobster Market

Advanced Driver Assistance Systems (ADAS) Market

Fluid Management System Market